NINGBO INNO PHARMCHEM CO.,LTD. is highlighting the pivotal role of 1-(2-Iodoethyl)-4-octylbenzene, a compound with CAS number 162358-07-8, within the pharmaceutical manufacturing landscape. As a key 'pharmaceutical intermediate', this substance is instrumental in the complex synthesis of vital medications, particularly serving as a precursor for Fingolimod Hydrochloride. Its typical presentation as a light yellow liquid is a standard characteristic observed by industry professionals.

The chemical industry relies heavily on the precise 'organic synthesis' of intermediates to build more complex molecules. 1-(2-Iodoethyl)-4-octylbenzene is a prime example of such a compound, enabling efficient and targeted reactions. Its specific function as a 'fingolimod hydrochloride intermediate' makes it a sought-after material for companies involved in producing treatments for neurological disorders. This highlights the critical nature of dependable 'chemical synthesis' chains.

The global market for chemical intermediates sees consistent interest in compounds like 1-(2-Iodoethyl)-4-octylbenzene, as evidenced by frequent 'buy 1-(2-iodoethyl)-4-octylbenzene' inquiries. NINGBO INNO PHARMCHEM CO.,LTD. understands the necessity of providing materials that meet rigorous pharmaceutical standards. This includes ensuring high purity and consistent batch-to-batch quality, which is vital for any 'pharmaceutical intermediate synthesis' process.

The compound, also referred to by synonyms like 4-octylphenethyl iodide, is a testament to the advancements in chemical manufacturing. The 'CAS 162358-07-8' serves as an essential identifier, ensuring that the correct material is procured for specific applications. For businesses in 'drug discovery', having access to such well-characterized intermediates accelerates research and development timelines.

NINGBO INNO PHARMCHEM CO.,LTD. is committed to being a reliable partner for the pharmaceutical industry. We focus on providing essential chemical building blocks like 1-(2-Iodoethyl)-4-octylbenzene, thereby supporting the production of safe and effective medications. Our goal is to facilitate the seamless progress of drug development and manufacturing, contributing to better health outcomes worldwide.